Expanding on their infectious disease deal, Sanofi turns to Evotec for its drug discovery expertise
French pharma giant Sanofi has turned to Evotec for some help in creating new translational efforts out of a slate of discovery programs.
The contract …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
